Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. Together with our research collaborations with premiere institutions like Cancer Research UK, The Institute of Cancer Research, The Netherlands Cancer Institute, and the Crick Institute we are pioneering validated approaches to DDR drug discovery. Visit our website at https://www.artios.com/ for more information.
Artios is based at the Babraham Campus in Cambridge, UK. If you are interested in working at Artios and have the qualities to be part of our team, please submit your application via our website. We are also very mindful of scams that involve recruitment. At this time please note we are currently not working with any third parties in India for recruitment.
Company Details
- Employees
- 118
- Founded
- -
- Address
- The Glenn Berge Building, Babraham Research Campus,united States
- Phone
- 4401223804180
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- artiospharma.com
- Keywords
- DNA damage response and oncology.
- HQ
- Cambridge
Artios Questions
Artios's helpline number is 4401223804180
Artios's website is artiospharma.com
Artios's LinkedIn profile is https://www.linkedin.com/company/artios-pharma-ltd
Artios has
118 employees.
View email and phone details for 118
employees at Artios.
Artios's industry is
Biotechnology Research
Artios's support email address is info@artiospharma.com
Artios's categories are Biotechnology Research
Artios's founding year is 2016
